| |
Short Duration (4, 6 weeks) Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
|
| |
| |
https://clinicaltrials.gov/ct2/show/NCT02175966?term=fourward&rank=1
This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified June 2014 by Bristol-Myers Squibb
Estimated Enrollment: 30
Study Start Date: July 2014
Estimated Study Completion Date: June 2015
|
|
| |
| |
|
|
|
